126 related articles for article (PubMed ID: 1680945)
41. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Beal MF
Ann Neurol; 1992 Feb; 31(2):119-30. PubMed ID: 1349466
[TBL] [Abstract][Full Text] [Related]
42. Neuromelanin and Parkinson's disease.
Marsden CD
J Neural Transm Suppl; 1983; 19():121-41. PubMed ID: 6321645
[TBL] [Abstract][Full Text] [Related]
43. Multi-target-directed ligands to combat neurodegenerative diseases.
Cavalli A; Bolognesi ML; Minarini A; Rosini M; Tumiatti V; Recanatini M; Melchiorre C
J Med Chem; 2008 Feb; 51(3):347-72. PubMed ID: 18181565
[No Abstract] [Full Text] [Related]
44. Metabolic regulation in the release and action of excitatory and inhibitory amino acids in the central nervous system.
Watkins JC
Biochem Soc Symp; 1972; (36):33-47. PubMed ID: 4155630
[No Abstract] [Full Text] [Related]
45. [Changes in brain level of neurotransmitters in Alzheimer's disease].
Shini H; Ichimiya Y; Kosaka K; Iitsuka R
Seishin Shinkeigaku Zasshi; 1988; 90(10):863-9. PubMed ID: 2908004
[No Abstract] [Full Text] [Related]
46. Ca(2+)-dependent and -independent processes in transmitter release from the motor nerve terminals of frog.
Maeno T
Jpn J Physiol; 1993; 43 Suppl 1():S119-24. PubMed ID: 7903713
[No Abstract] [Full Text] [Related]
47. Aging of cerebellar Purkinje cells.
Zhang C; Zhu Q; Hua T
Cell Tissue Res; 2010 Sep; 341(3):341-7. PubMed ID: 20652318
[TBL] [Abstract][Full Text] [Related]
48. Brain catecholamines and neurological disease.
Wurtman RJ; Moskowitz MA
Trans Am Neurol Assoc; 1974; 99():149-59. PubMed ID: 4282535
[No Abstract] [Full Text] [Related]
49. Listening to the brain: microelectrode biosensors for neurochemicals.
Dale N; Hatz S; Tian F; Llaudet E
Trends Biotechnol; 2005 Aug; 23(8):420-8. PubMed ID: 15950302
[TBL] [Abstract][Full Text] [Related]
50. Multiple dopamine receptors: relevance for neurodegenerative disorders.
Strange PG
Biochem Soc Trans; 1994 Feb; 22(1):155-9. PubMed ID: 8206214
[No Abstract] [Full Text] [Related]
51. Role of inflammatory factors in neurodegeneration.
Członkowska A; Kurkowska-Jastrzebska I; Członkowski A
Neurol Neurochir Pol; 2001; 35 Suppl 3():13-22. PubMed ID: 12001649
[No Abstract] [Full Text] [Related]
52. Substitute and alternative neurotransmitters in neuropsychiatric illness.
Baldessarini RJ; Fischer JE
Arch Gen Psychiatry; 1977 Aug; 34(8):958-64. PubMed ID: 19004
[TBL] [Abstract][Full Text] [Related]
53. A bioenergetic approach to the nerve terminal.
Nicholls D
Biochim Biophys Acta; 1992 Jul; 1101(2):264-5. PubMed ID: 1352992
[No Abstract] [Full Text] [Related]
54. Dysmenorrhea and uterine neurotransmitters.
Sjöberg NO
Acta Obstet Gynecol Scand Suppl; 1979; 87():57-9. PubMed ID: 37691
[No Abstract] [Full Text] [Related]
55. Topochemical aspects of nucleic acid metabolism within the neuronal-neuroglia unit of cerebellum Purkinje cells.
Pevzner LZ
Brain Res; 1972 Nov; 46():329-39. PubMed ID: 4117876
[No Abstract] [Full Text] [Related]
56. Neurochemical abnormalities in Huntington's disease: neurotoxic mechanisms and neurotransmitter changes.
Reynolds GP; Pearson SJ
J Neurol Sci; 1992 Dec; 113(2):230-3. PubMed ID: 1362587
[No Abstract] [Full Text] [Related]
57. Neurotransmitters and neuropeptides in depression.
Bao AM; Ruhé HG; Gao SF; Swaab DF
Handb Clin Neurol; 2012; 106():107-36. PubMed ID: 22608619
[No Abstract] [Full Text] [Related]
58. Cytoskeleton dynamics during neurotransmitter release.
Trifaró JM; Vitale ML
Trends Neurosci; 1993 Nov; 16(11):466-72. PubMed ID: 7507620
[TBL] [Abstract][Full Text] [Related]
59. Neurotransmitter receptors-biochemistry and alterations in nueropsychiatric disorders.
Olsen RW; Reisine TD; Yamamura HI
Life Sci; 1980 Sep; 27(10):801-8. PubMed ID: 6251327
[No Abstract] [Full Text] [Related]
60. Quantitative dissection of human brain areas: relevance to transmitter analyses.
Wuketich S; Riederer P; Jellinger K; Ambrozi L
J Neural Transm Suppl; 1980; (16):53-67. PubMed ID: 6107333
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
